Lake Street Capital Issues Pessimistic Forecast for P3 Health Partners (NASDAQ:PIII) Stock Price

P3 Health Partners (NASDAQ:PIII) had its price objective lowered by analysts at Lake Street Capital from $12.50 to $4.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Lake Street Capital’s price objective would indicate a potential upside of 36.05% from the stock’s previous close.

A number of other analysts also recently commented on PIII. Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. BTIG Research restated a “neutral” rating on shares of P3 Health Partners in a report on Friday, December 12th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $4.00.

P3 Health Partners Price Performance

P3 Health Partners stock opened at $2.94 on Friday. The firm’s 50-day simple moving average is $2.46 and its 200 day simple moving average is $5.17. The firm has a market capitalization of $21.20 million, a PE ratio of -0.07 and a beta of 0.86. P3 Health Partners has a 52 week low of $1.52 and a 52 week high of $11.30. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 2.29.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings results on Thursday, March 26th. The company reported ($23.02) EPS for the quarter, missing the consensus estimate of ($8.06) by ($14.96). P3 Health Partners had a negative return on equity of 498.57% and a negative net margin of 10.14%.The business had revenue of $384.81 million during the quarter, compared to the consensus estimate of $357.65 million. On average, equities research analysts predict that P3 Health Partners will post -0.67 EPS for the current fiscal year.

Hedge Funds Weigh In On P3 Health Partners

A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC raised its position in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,678 shares of the company’s stock after purchasing an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned 0.37% of P3 Health Partners worth $239,000 at the end of the most recent quarter. 7.75% of the stock is owned by institutional investors.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.